Molecular Moments Podcast

On this episode of Molecular Moments, Jim McNally, Ph.D., speaks with Adam Stasio, president of SciMed, whose mission is to craft software that frees their clients to do what they do best: advance cutting-edge technology, improve lives, and effect social change. They discuss their shared passion for problem-solving and how the right mindset helps find solutions to new issues that arise.

They talk about the role of data privacy and...

On this episode of Molecular Moments, Chad Briscoe speaks with Dr. David Berkowitz, Director of the Division of Chemistry at the National Science Foundation (NSF) and a Willa Cather Professor of Chemistry at the University of Nebraska-Lincoln, and co-lead of the Nebraska Drug Discovery & Development Pipeline. David shares how he got his early beginnings in science as an undergrad studying endocrinology at the University of Chic...

On this episode of Molecular Moments, Chad Briscoe talks with his brother, Rick Briscoe, Senior VP of Safety Assessment and Research Operations at Cerevel Therapeutics. 

Rick talks with Chad about how he found his love of the sciences through a scuba diving class in high school, which sparked his interest in biology and led him to take a neuroscience class during his freshman year of college. Rick goes on to share how working at a...

On this episode of Molecular Moments, BioAgilytix Scientific Officers Amanda Hays, Ph.D., and Lynn Kamen, Ph.D. speak with Stephanie Pasas-Farmer, Ph.D., President of both Ariadne Software and BioData Solutions.

They discuss how Stephanie went from a career as a bioanalytical chemist to being an entrepreneur in big data and machine learning. They discuss how she became a founder of a company, building a robust team with vari...

On this episode of Molecular Moments, Lynn Kamen, Ph.D., and Michelle Miller, Ph.D. DABT discuss their very different journeys to BioAgilytix as Scientific Officers. Despite different initial career paths, they both ended up working in bioanalysis, supporting the development of novel therapeutics. The pair discuss their favorite aspects of their day-to-day tasks at BioAgilytix, Scientific Office Hours, mentors (unofficial or otherw...

On this episode of Molecular Moments, Dr. Jim McNally chats with DMPK Senior Director Dr. David Johnson, Ph.D., from BioAgilytix San Diego. They discuss how his childhood breakfast cereal formed an interest in science which eventually led to his pursuit of biochemistry and a career in small molecule therapeutics. 

David, known as Dr. J to his friends and colleagues, shares his goal of helping people get a better quality of li...

In this episode of Molecular Moments, Dr. Jim McNally chats with Tricia Sterling, Vice President of Patient Affairs at Aeglea. Tricia shares some of her experiences working with patients in the biotech industry for over a decade.

Jim and Tricia’s discussion focuses on the patient side of pharmaceutical research, particularly in relation to rare diseases, as they affect 1 out of 15 people worldwide. They discuss the patient j...

On this episode of Molecular Moments, Scientific Officer Amanda Hayes speaks with BioAgilytix colleague Dr. Dave Williams, Vice President of Operations. Dave has spent the last decade of his career supporting and leading bioanalytical programs at contract research organizations (CROs) in his pursuit of solutions for scientific problems. They discuss what inspired him to study science, his career path to BioAgilytix, working with fl...

On this episode of Molecular Moments, Dr. Chad Briscoe is joined by Dr. Kevin Bateman, Scientific Associate and Vice President at Merck. Kevin is a veteran of the bioanalytical industry and is known for innovating and encouraging new technology research. With over 25 years at Merck, Kevin shares a bit about his journey that started in an analytical lab focusing on biomarkers, pharmacology, biology, and clinical trials. They talk ab...

On this episode of Molecular Moments, Jim McNally chats with Angela Luttick, co-founder of 360biolabs & Executive Vice President, Commercial. 360biolabs, a BioAgilytix company has labs located in Melbourne and Brisbane and is the most comprehensive specialty lab in the region. They discuss the origins of 360biolabs, its role in early phase clinical trials, vaccine studies taking plac...

In this episode of Molecular Moments, Chad Briscoe sits down with Neil Spooner, founder and director of Spooner Bioanalytical Solutions and senior editor of the journal, “Bioanalysis.” Based in England, Neil shares a bit of his background in LC-MS, his first taste of quantitative bioanalysis at Huntingdon Life Sciences, helping organizations understand their own technologies and the exciting challenges that bioanalytica...

On this episode of Molecular Moments, BioAgilytix Chief Scientific Officer Jim McNally chats with the company’s President & CEO about the exciting new updates that are putting BioAgilytix at the forefront of biotech on a global level. From multiple acquisitions to a new investor that sees the bigger picture, Datin shares how these opportunities came to be and what major deciding factors came into play when finalizing the ...

Chad Briscoe and Jim McNally talk with Emmy-winning journalist and producer Charles Sabine on this episode of Molecular Moments. Their discussion centers around rare diseases, gene therapy and Huntington's Disease (HD). Charles, a carrier of the HD gene who has lost several immediate family members to the disease, is an ardent advocate for patients and families suffering from rare degenerative diseases.

From covering war zones to ...

On this episode of Molecular Moments, Chad Briscoe chats with Dr. Jennifer Zemo, Director, Bioanalytical Operations at BioAgilytix. She’s a great leader, mentor and scientist with a love for helping people and the sciences. They discuss her start as a chemistry major in college, which led to her Ph.D. in Biological Chemistry and eventually to joining BioAgilytix 8 years ago. A large molecule expert, Jennifer shares how she we...

In this episode of Molecular Moments, Chad talks with Dr. Afshin Safavi, a bioanalytical thought leader, BioAgilytix founder, and board member. Afshin shares how his interest in the sciences was sparked by his mother's perfumes and household items, and how he went from pursuing a career in electronic engineering to dentistry and then into pharmaceuticals!

They also discuss Afshin’s upcoming children's book, the value of ment...

In this episode, Chad sits down with Jeff Sutherland, founder and CEO of Canine Biologics. With over 500,000 dogs in the US and Canada diagnosed with cancer each year, Jeff’s company addresses nutritional needs for dogs to fight terminal diseases based on tumor type. They discuss how Jeff started off as pre-med in college before shifting his focus to marketing, then to dental technology, and finally to IT with a master's in A...

In today's episode, Chad sits down with guest scientists, Drs. Jolly Mazumdar and Tim Chendrimada, CEO, and CSO of Chimeron Bio. Two different beginnings; one in the sciences studying bugs and infectious diseases and the other in agriculture, specifically coffee beans! They talk to Chad about how their very different paths led them to become a dynamic duo in the next generation of RNA therapeutics. 

From Tim asking a scientis...

In today's episode, Chad sits down with guest scientist, Dr. John Smeraglia, Vice President & Head of Translational Biomarkers and Bioanalysis at UCB. John is an experienced pharma leader in the development and service side of the industry.

John talks to Chad about his experiences working in the UK, such as picking up basketball and taking apart a massive magnetic sector mass spectrometer in his early days of working in bioana...

In today’s episode, Chad sits down with Angela Stoyanovitch, a director of business development at BioAgilytix and founder of the Legal Drugs podcast. She’s a podcaster, veteran business developer, social media strategist and consultant who kicked off her career in research who has held business development roles across pre-clinical research, bioanalysis and in basic research. They discuss how she fell in love with the ...